MedPath

Randomized, trial evaluating efficacy of add-on imipramine in the control of Dental Pai

Phase 4
Completed
Conditions
Health Condition 1: null- Indication for forceps extraction of one or more teeth and expected to experience pain.
Registration Number
CTRI/2011/12/002203
Lead Sponsor
Postgraduate Institute of Medical Education and Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
66
Inclusion Criteria

Age between 18 to 30 years.

Either sex.

Indication for forceps extraction of one or more teeth and expected to experience pain.

Willing to give informed consent

Exclusion Criteria

Grade 3 mobile tooth.

Any local or systemic conditions contraindicating tooth extraction

Pregnancy or breast-feeding

Alcohol or substance abuse

Any serious medical or psychiatric disorder

History of stomach ulcers, stomach bleed, or other bleeding disorders

Use of a prescription or over-the-counter (OTC) drug with which administration of ibuprofen or any other NSAID; paracetamol; or codeine or any other opioid is contraindicated (including: antipsychotics, antianxiety agents, or other central nervous system depressants [including alcohol])

Patient has hypersensitivity, allergy, or clinically significant intolerance to any medications to be used in the study, or related drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SPRID 0-6 (sum of pain intensity difference scores and pain relief scores from 0 to 6 hours after dosing)Timepoint: SPRID 0-6 (sum of pain intensity difference scores and pain relief scores from 0 to 6 hours after dosing)
Secondary Outcome Measures
NameTimeMethod
SPRID2, and SPRID3 post-dosing, TOTPAR2, TOTPAR3, and TOTPAR6.Timepoint: 0, 2 and 6 hour;The cumulative proportion of subjects achieving meaningful and first perceptible relief (confirmed by meaningful relief) by each post-dosing time-point.Timepoint: 0, 2 and 6 hour
© Copyright 2025. All Rights Reserved by MedPath